Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

The gut microbiome affects the development of alopecia areata.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Stress can cause hair loss and trigger autoimmunity by damaging hair follicle cells.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Restoring hair follicle immune privilege may help treat alopecia areata.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

ILC1-like cells can independently cause alopecia areata.

A new mouse model for vitiligo helps study immune responses and potential treatments.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

taVNS reduces vitiligo symptoms in mice.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.